Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial of Bendamustine And Rituximab for Patients With Previously Untreated Extranodal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma
This study is ongoing, but not recruiting participants.
Study NCT01015248 Information provided by Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
First Received on November 17, 2009. Last Updated on July 5, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
MALT LYMPHOMA
Additional conditions recognized in this trial
Lymphoma
Lymphoma, B-Cell, Marginal Zone
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma, B-Cell
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
Rituximab and Bendamustine
Additional drug interventions recognized in this trial
Bendamustine
Nitrogen Mustard Compounds
Rituximab
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Back to top of Main Content
